Real-world Studies In Migraine

Over the last several years, there have been a multitude of new therapeutic drugs for the management of migraine and several real world studies assessing the management of various aspects of migraine. This collection of articles include manuscripts published on real world evidence in the past two years in Headache: The Journal of Head and Face Pain.

Target Audience

Healthcare Professionals

Learning Objectives

To understand the current state of migraine management through the review of real world evidence studies on migraine in the last 2 years.

Activity Disclosure

No commercial support has been accepted related to the development or publication of this activity.

Course summary

Available credit: 
  • 4.50 ABPN-approved Self-Assessment credit(s)
  • 4.50 AMA PRA Category 1 Credit(s)™
Course opens: 
11/21/2025
Course expires: 
11/20/2027
Cost:
$0.00
Rating: 
0
Arathi Nandyala, MD

Arathi Nandyala, MD

Arathi Nandyala, MD discloses the following: Dr. Nandyala reports no conflicts of interest.

Keiko Ihara, MD

Keiko Ihara, MD

Keiko Ihara, MD discloses the following: Dr. Ihara receives Postdoctoral Fellowship Grant from the American Heart Association with funds paid to her institution.

Minali Nigam, MD

Minali Nigam, MD

Minali Nigam, MD discloses the following: Dr. Nigam reports no conflicts of interest.

Edina Szabo, MD

Edina Szabo, MD

Edina Szabo, MD discloses the following: Dr. Szabo reports no conflicts of interest.

John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

John Wiley and Sons, Inc. designates this journal-based CME activity for a maximum of 4.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.

The American Board of Psychiatry and Neurology has reviewed Behavior and Migraine and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

This activity is designed to be completed within 4.5 hours. To successfully earn credit, participants must access and complete the activity during the valid credit period, which is up to two years from initial publication.

Available Credit

  • 4.50 ABPN-approved Self-Assessment credit(s)
  • 4.50 AMA PRA Category 1 Credit(s)™

Price

Cost:
$0.00
Please login or register to take this course.